Title:
NOVEL CRYSTAL FORM OF 3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)-N-(2-HYDROXYETHOXY)-5-(3-OXO-[1,2]OXAZINAN-2-YLMETHYL)BENZAMIDE
Document Type and Number:
WIPO Patent Application WO/2014/081025
Kind Code:
A1
Abstract:
This invention relates to an I-form crystal of the free form of 3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-N-(2-hydroxyethoxy)-5-(3-oxo-[1,2]-oxazinan-2-ylmethyl)benzamide, the crystal, in analysis by X-ray powder diffraction with CuKα (1.54060 Å) as an X-ray source, giving a pattern which includes peaks at diffraction angles represented by 2θ of 14.9, 16.9, and 23.1º (±0.2º). The crystal is physicochemically stable and is useful as a raw drug for medicines.
Inventors:
UETO TAKAMITSU (JP)
TAKATA NORIYUKI (JP)
TAKATA NORIYUKI (JP)
Application Number:
PCT/JP2013/081589
Publication Date:
May 30, 2014
Filing Date:
November 25, 2013
Export Citation:
Assignee:
CHUGAI PHARMACEUTICAL CO LTD (JP)
International Classes:
C07D265/02; A61K31/535; A61P3/10; A61P9/00; A61P9/04; A61P9/10; A61P11/00; A61P11/06; A61P17/06; A61P19/02; A61P25/28; A61P29/00; A61P31/04; A61P31/18; A61P35/00; A61P37/06; A61P41/00; A61P43/00
Domestic Patent References:
WO2006011466A1 | 2006-02-02 |
Foreign References:
KR101153556B1 | 2012-06-11 |
Attorney, Agent or Firm:
HARUNA, Masao et al. (JP)
Masao Haruna (JP)
Masao Haruna (JP)
Download PDF: